Study identification

EU PAS number

EUPAS31926

Study ID

44354

Official title and acronym

A Global Cross-sectional Survey to Capture Awareness and Knowledge of Mesenchymal Stem Cell (MSC) Therapy by Gastroenterologists and Colorectal Surgeons

DARWIN EU® study

No

Study countries

Australia
Austria
Canada
Denmark
France
Germany
Israel
Italy
Japan
Korea, Republic of
Netherlands
Spain
Switzerland
United Kingdom
United States

Study description

This study is an observational, multinational, cross-sectional cohort study. This study will be assessed by means of a study specific online survey designed to describe current perspectives, awareness, and knowledge of MSC therapy amongst gastroenterologists and colorectal surgeons. All the eligible physicians would be asked to fill a web-based survey which would be containing approximately 37 multiple choice questions related to sociodemographic variables and study outcomes. The survey would take approximately 15 minutes to complete. This study will collect the data via Qualtrics, web-based survey platform, and via email at a single time point. The study will enroll approximately 387 physicians. The study will be conducted in 15 countries. The overall duration of the survey will be approximately 15 months.

Study status

Finalised
Research institutions and networks

Institutions

IQVIA
United Kingdom
First published:
22/04/2024
Institution Non-Pharmaceutical company ENCePP partner

Contact details

Rachele Ciccocioppo

Primary lead investigator

Study timelines

Date when funding contract was signed

Planned:
Actual:

Study start date

Planned:
Actual:

Data analysis start date

Planned:
Actual:

Date of final study report

Planned:
Actual:
Sources of funding
Pharmaceutical company and other private sector 

More details on funding

Takeda
Regulatory

Was the study required by a regulatory body?

No

Is the study required by a Risk Management Plan (RMP)?

Not applicable